Role of plasma osteopontin as a biomarker in locally advanced breast cancer.

Anborgh, Pieter H; Caria, Laura Br; Chambers, Ann F; Tuck, Alan B; Stitt, Larry W; Brackstone, Muriel

Anborgh, Pieter H; Caria, Laura Br; Chambers, Ann F; Tuck, Alan B; Stitt, Larry W; Brackstone, Muriel.

Afiliación

Anborgh PH; London Regional Cancer Program, University of Western Ontario 790 Commissioners Road East, London, ON N6A 4L6, Canada.
Caria LB; London Regional Cancer Program, University of Western Ontario 790 Commissioners Road East, London, ON N6A 4L6, Canada.
Chambers AF; London Regional Cancer Program, University of Western Ontario 790 Commissioners Road East, London, ON N6A 4L6, Canada.
Tuck AB; London Regional Cancer Program, University of Western Ontario 790 Commissioners Road East, London, ON N6A 4L6, Canada.
Stitt LW; London Regional Cancer Program, University of Western Ontario 790 Commissioners Road East, London, ON N6A 4L6, Canada.
Brackstone M; London Regional Cancer Program, University of Western Ontario 790 Commissioners Road East, London, ON N6A 4L6, Canada.

Am J Transl Res ; 7(4): 723-32, 2015.

Article en En | MEDLINE | ID: mdl-26064440

Palabras clave

Locally advanced breast cancer; neoadjuvant therapy; osteopontin; predictive biomarker; prognostic biomarker

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Am J Transl Res Año: 2015 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google